BIOQuebec

BIOQuebec
Canada's Research-Based Pharmaceutical Companies

Canada's Research-Based Pharmaceutical Companies

November 07, 2013 10:21 ET

BIOQuebec and Rx&D join forces to strengthen Canada's biotechnology sector

MONTREAL, QUEBEC--(Marketwired - Nov. 7, 2013) - In an effort to enhance networking opportunities and develop partnerships that will lead to the discovery of the next generation of life-saving therapies, BIOQuébec and Canada's Research-Based Pharmaceutical Companies (Rx&D) have announced an exciting new joint-membership initiative for emerging biopharmaceutical companies and associated stakeholders in Québec.

"Emerging biotech companies and clinical/contract research organizations (CROs) play a vital role in the R&D ecosystem. They share a common interest with major biopharmaceutical companies in developing innovative medicines, "said Mario Lebrun, General Manager of BIOQuébec on the occasion of the announcement. "We believe that this initiative will provide them with increased networking opportunities and contribute to the development of new partnerships, thereby fostering their development."

This joint initiative provides an exciting opportunity for BIOQuébec members to obtain membership within Rx&D as a Biopharmaceutical or an Associate member, thus gaining access to a number to key benefits:

  • Representation on the Rx&D Board of Directors through two elected positions;
  • Access to the environmental pulse of the innovative industry;
  • Access to industry leaders with global experience;
  • Access to a full range of expertise in government relations, intellectual property, policy development, scientific and regulatory affairs, public affairs, communications, and stakeholder relations; and,
  • Timely information on important, ever-changing issues, developments, legislations and regulations within the biopharmaceutical marketplace through networking forums.

"This initiative is a great example of our continuing efforts to position Quebec as a world leader in the life sciences sector," added Rx&D President Russell Williams. "Expanding upon the relationship between BIOQuébec and Rx&D is possible because of our shared commitment to Quebec and of the progress the innovative biopharmaceutical industry continues to make for the benefit of Quebecers and Canadians."

About BIOQuébec

Founded in 1991, BIOQuébec is the only association bringing together Québec biotechnology companies. Its mission is to foster the economic interest of its members and to ensure their growth. BIOQuébec's member companies and organizations work predominantly in application sectors such as human health and animal health.

About Rx&D

Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents the men and women working for more than 50 member companies which invest more than $1 billion in research and development each year to fuel Canada's knowledge-based economy, contributing over $3 billion to the Canadian economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, private payers, healthcare professionals and stakeholders in a highly ethical manner.

Contact Information